4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)[J]. Lancet,1998,352(9131) : 837-853.
1Weyer.Dificiency in AIR predict IGT and Type 2 diabetes[J].Diabetes Care,2001,24(2):89-94.
2Ilkova H,Glaser B,Tunekale A,et al.Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment[J].DiabetesCare,1997,20(9):1353-1356.
3Weyer. Dificiency in AIR predict IGT and Type 2 diabetes. Diabetes Care, 2001,24 : 89-94.
4Haffner SM, Miettinen H, Gaskill SP, et al. Decreased insulin secretion and increased insulin resistance are independently related to the 7-year risk of NIDDM in Mexican-Americans. Diabetes, 1995,44: 1386-1391.
5Bruce DG, Chisholm DJ, Leonare H, et al. Physiological importance of deficiency in early prandial insulin secretion in non-in-sulin-dependent diabetes. Diabetes, 1988,37: 736-743.
6Bruttomesso D, Pianta A, Mari A, et al. Restoration of early rise in plasma insulin levels improves the glucose tolerance of type 2 diabetic patients. Diabetes, 1999,48: 99-105.
7Ilkova H, glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care, 1997,20:1353-1356.
8Walton C, Godsland IF, Proudler AJ, et al. Effect of body mass index and fat distribution on insulin sensitivity, secretion, and clearance in nonobese healthy men. J Clin Endocrinol Metab,1992,75: 170-175.
9Purrello F, Rabuazza AM. Metabolic factors that affect betacell function and survival. Diabet Nutr Metab, 2000, 13: 84-91.
10Sivitz WI. Lipotoxieity and glueotoxieity in type 2 diabetes. Effects on development and progression. Postgrad Med, 2001,109: 55-59,63-64.
4Ilkova H,Glaser B, Tunckale A, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment[J]. Diabetes Care, 1997, 20(9) :1353-1355.
5Li Y, Xu W, Liao Z, et al. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function[J]. Diabetes Care, 2004,27(11) :2597-2602.
6Kahn SE, Half her SM, Heise MA, et al. Glycemie durability of rosiglitazone, metformin, or glyburide monotherapy[J].N Engl J Med,2006,355(23) :Z427-Z443.
7Turner RC, Cull CA, Frighi V, et al. Glyeemic control with diet, sulfonylurea,metformin,or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49) [J]. JAMA, 1999, 281( 21) :2005- 2012.
